Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).

Jiamsakul A, Kiertiburanakul S, Ng OT, Chaiwarith R, Wong W, Ditangco R, Nguyen KV, Avihingsanon A, Pujari S, Do CD, Lee MP, Ly PS, Yunihastuti E, Kumarasamy N, Kamarulzaman A, Tanuma J, Zhang F, Choi JY, Kantipong P, Sim B, Ross J, Law M, Merati TP; TREAT Asia HIV Observational Database of IeDEA Asia-Pacific.

HIV Med. 2019 Apr 12. doi: 10.1111/hiv.12734. [Epub ahead of print]

PMID:
30980495
2.

Prediction Model of Pre-treatment HIV RNA Levels in Naïve Thai HIV-infected Patients: Application for Resource-limited Settings.

Pongpech N, Avihingsanon A, Chaiwarith R, Kantipong P, Boettiger D, Ross J, Kiertiburanakul S.

Southeast Asian J Trop Med Public Health. 2018 Nov;49(6):965-974.

PMID:
30930503
3.

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.

Ku SW, Jiamsakul A, Joshi K, Pasayan MKU, Widhani A, Chaiwarith R, Kiertiburanakul S, Avihingsanon A, Ly PS, Kumarasamy N, Do CD, Merati TP, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Khusuwan S, Sim BLH, Ng OT, Ratanasuwan W, Ross J, Wong WW; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific.

J Int AIDS Soc. 2019 Mar;22(3):e25264. doi: 10.1002/jia2.25264.

4.

Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD).

Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Lam W, Chaiwarith R, Wong WW, Kamarulzaman A, Kantipong P, Avihingsanon A, Nguyen KV, Tanuma J, Ng OT, Sim BL, Merati TP, Choi JY, Ditangco R, Yunihastuti E, Sun LP, Do CD, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific.

Antivir Ther. 2019 Mar 5. doi: 10.3851/IMP3298. [Epub ahead of print]

PMID:
30833516
5.

The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.

Ahn MY, Jiamsakul A, Khusuwan S, Khol V, Pham TT, Chaiwarith R, Avihingsanon A, Kumarasamy N, Wong WW, Kiertiburanakul S, Pujari S, Nguyen KV, Lee MP, Kamarulzaman A, Zhang F, Ditangco R, Merati TP, Yunihastuti E, Ng OT, Sim BLH, Tanuma J, Ratanasuwan W, Ross J, Choi JY; IeDEA Asia-Pacific.

J Int AIDS Soc. 2019 Feb;22(2):e25228. doi: 10.1002/jia2.25228.

6.

Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program.

Teeraananchai S, Puthanakit T, Kerr SJ, Chaivooth S, Kiertiburanakul S, Chokephaibulkit K, Bhakeecheep S, Teeraratkul A, Law M, Ruxrungtham K.

J Virus Erad. 2019 Jan 1;5(1):33-40.

7.

Diabetes mellitus burden among people living with HIV from the Asia-Pacific region.

Han WM, Jiamsakul A, Kiertiburanakul S, Ng OT, Sim BL, Sun LP, Van Nguyen K, Choi JY, Lee MP, Wong WW, Kamarulzaman A, Kumarasamy N, Zhang F, Tanuma J, Do CD, Chaiwarith R, Merati TP, Yunihastuti E, Pujari S, Ditangco R, Khusuwan S, Ross J, Avihingsanon A; IeDEA Asia-Pacific.

J Int AIDS Soc. 2019 Jan;22(1):e25236. doi: 10.1002/jia2.25236.

8.

Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD).

Bijker R, Jiamsakul A, Uy E, Kumarasamy N, Ditango R, Chaiwarith R, Wong WW, Avihingsanon A, Sun LP, Yunihastuti E, Pujari S, Do CD, Merati TP, Kantipong P, Nguyen KV, Kamarulzaman A, Zhang F, Lee MP, Choi JY, Tanuma J, Ng OT, Sim B, Ross J, Kiertiburanakul S; TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific.

HIV Med. 2019 Mar;20(3):183-191. doi: 10.1111/hiv.12687. Epub 2019 Jan 8.

PMID:
30620108
9.

Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality.

Pasayan MKU, S Mationg ML, Boettiger D, Lam W, Zhang F, Ku SW, Merati TP, Chaiwarith R, Cuong DD, Yunihastuti E, Kiertiburanakul S, Van Kinh N, Avihingsanon A, Sun LP, Kamarulzaman A, Kantipong P, Kumarasamy N, Pujari S, Heng Sim BL, Ng OT, Choi JY, Tanuma J, Ross J, A Ditangco R.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):436-443. doi: 10.1097/QAI.0000000000001933.

PMID:
30550488
10.

Brief Report: Malignancies in Adults Living With HIV in Asia.

Jiamsakul A, Polizzotto M, Wen-Wei Ku S, Tanuma J, Hui E, Chaiwarith R, Kiertiburanakul S, Avihingasanon A, Yunihastuti E, Kumarasamy N, Ly PS, Pujari S, Ditangco R, Do CD, Merati TP, Kantipong P, Zhang F, Van Nguyen K, Kamarulzaman A, Choi JY, Sim BLH, Ng OT, Ross J, Wong W.

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):301-307. doi: 10.1097/QAI.0000000000001918.

PMID:
30531303
11.

Epidemiology and outcomes of dengue in kidney transplant recipients: A 20-year retrospective analysis and comparative literature review.

Pinsai S, Kiertiburanakul S, Watcharananan SP, Kantachuvessiri S, Boongird S, Bruminhent J.

Clin Transplant. 2019 Jan;33(1):e13458. doi: 10.1111/ctr.13458. Epub 2018 Dec 26.

PMID:
30506903
12.

Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.

Joshi K, Boettiger D, Kerr S, Nishijima T, Van Nguyen K, Ly PS, Lee MP, Kumarasamy N, Wong W, Kantipong P, Cuong DD, Kamarulzaman A, Choi JY, Zhang F, Chaiwarith R, Ng OT, Kiertiburanakul S, Sim BLH, Merati TP, Yunihastuti E, Ditangco R, Ross J, Pujari S.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1209-1216. doi: 10.1002/pds.4657. Epub 2018 Sep 24.

PMID:
30246898
13.

Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia.

Jiamsakul A, Kerr SJ, Kiertiburanakul S, Azwa I, Zhang F, Chaiwarith R, Wong W, Ly PS, Kumarasamy N, Ditangco R, Pujari S, Yunihastuti E, Do CD, Merati TP, Nguyen KV, Lee MP, Choi JY, Oka S, Kantipong P, Sim BLH, Ng OT, Ross J, Law M; TREAT Asia HIV Observational Database (TAHOD).

AIDS Care. 2018 Dec;30(12):1560-1566. doi: 10.1080/09540121.2018.1499859. Epub 2018 Jul 18.

PMID:
30021450
14.

Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand.

Kiertiburanakul S, Wongprasit P, Phuphuakrat A, Chotiprasitsakul D, Sungkanuparph S.

PLoS One. 2018 Jun 27;13(6):e0198654. doi: 10.1371/journal.pone.0198654. eCollection 2018.

15.

A Multicenter Study of Clinical Presentations and Predictive Factors for Severe Manifestation of Dengue in Adults.

Temprasertrudee S, Thanachartwet V, Desakorn V, Keatkla J, Chantratita W, Kiertiburanakul S.

Jpn J Infect Dis. 2018 May 24;71(3):239-243. doi: 10.7883/yoken.JJID.2017.457. Epub 2018 Apr 27.

16.

Mortality following diagnosis of tuberculosis in HIV-infected patients in Asia.

Jiamsakul A, Yunihastuti E, Van Nguyen K, Merati TP, Do CD, Ditangco R, Ponnampalavanar S, Zhang F, Kiertiburanakul S, Lee MP, Avihingasanon A, Ng OT, Sim BL, Wong W, Ross J, Law M.

HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12621. [Epub ahead of print] No abstract available.

PMID:
29683253
17.

Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia.

Jiamsakul A, Lee MP, Nguyen KV, Merati TP, Cuong DD, Ditangco R, Yunihastuti E, Ponnampalavanar S, Zhang F, Kiertiburanakul S, Avihingasanon A, Ng OT, Sim BLH, Wong WW, Ross J, Law M.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):179-186. doi: 10.5588/ijtld.17.0348.

18.

Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region.

Bijker R, Choi JY, Ditangco R, Kiertiburanakul S, Lee MP, Siwamogsatham S, Pujari S, Ross J, Wong CY, Wong WW, Yunihastuti E, Law M.

Open AIDS J. 2017 Aug 21;11:52-66. doi: 10.2174/1874613601711010052. eCollection 2017.

19.

The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD).

Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY.

J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25016.

20.

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

Cahn P, Kaplan R, Sax PE, Squires K, Molina JM, Avihingsanon A, Ratanasuwan W, Rojas E, Rassool M, Bloch M, Vandekerckhove L, Ruane P, Yazdanpanah Y, Katlama C, Xu X, Rodgers A, East L, Wenning L, Rawlins S, Homony B, Sklar P, Nguyen BY, Leavitt R, Teppler H; ONCEMRK Study Group.

Lancet HIV. 2017 Nov;4(11):e486-e494. doi: 10.1016/S2352-3018(17)30128-5. Epub 2017 Sep 11.

PMID:
28918877

Supplemental Content

Loading ...
Support Center